Cargando…
Elevated RIPK3 correlates with disease burden in myelofibrosis
Autores principales: | Dill, Veronika, Wagner, Celina V., Keller, Eva C., Fernandez-Hernandez, Francisco Jose, Shoumariyeh, Khalid, Odinius, Timo O., Buschhorn, Lars, Hauch, Richard T., Suren, Christian, Hecker, Judith S., Herhaus, Peter, Sandherr, Michael, Schmidt, Burkhard, Slotta-Huspenina, Julia, Bassermann, Florian, Höckendorf, Ulrike, Jilg, Stefanie, Branca, Caterina, Vosberg, Sebastian, Jost, Philipp J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111350/ https://www.ncbi.nlm.nih.gov/pubmed/36453650 http://dx.doi.org/10.1182/bloodadvances.2021006838 |
Ejemplares similares
-
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies
por: Odinius, Timo O., et al.
Publicado: (2021) -
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
por: Jilg, Stefanie, et al.
Publicado: (2019) -
Transcriptomic profiling does not refine mastocytosis diagnosis
por: Buschhorn, Lars, et al.
Publicado: (2023) -
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
por: Reidel, Veronika, et al.
Publicado: (2018) -
RIPK3-dependent cell death and inflammasome activation in FLT3-ITD expressing LICs
por: Höckendorf, Ulrike, et al.
Publicado: (2016)